|
Volumn 5, Issue 12, 2014, Pages 1146-1147
|
Are we using the right pharmacological tools to target EphA4?
|
Author keywords
Compound 1; Eph ephrin antagonist; EphA4; Rhynchophylline; UniPR129
|
Indexed keywords
EPHRIN RECEPTOR A4;
RHYNCHOPHYLLINE;
SALICYLIC ACID;
4-(2,5-DIMETHYLPYRROL-1-Y1)-2-HYDROXYBENZOIC ACID;
INDOLE ALKALOID;
PYRROLE DERIVATIVE;
RHYNCOPHYLLINE;
SALICYLIC ACID DERIVATIVE;
ARTICLE;
DRUG ACTIVITY;
DRUG BIOAVAILABILITY;
DRUG RECEPTOR BINDING;
DRUG STABILITY;
DRUG TARGETING;
NONHUMAN;
PROTEIN PHOSPHORYLATION;
ANIMAL;
ANTAGONISTS AND INHIBITORS;
CHEMICAL STRUCTURE;
CHEMISTRY;
DRUG EFFECTS;
HUMAN;
METABOLISM;
NEURODEGENERATIVE DISEASES;
SIGNAL TRANSDUCTION;
ANIMALIA;
ANIMALS;
HUMANS;
INDOLE ALKALOIDS;
MODELS, MOLECULAR;
NEURODEGENERATIVE DISEASES;
PYRROLES;
RECEPTOR, EPHA4;
SALICYLATES;
SIGNAL TRANSDUCTION;
|
EID: 84918588154
PISSN: None
EISSN: 19487193
Source Type: Journal
DOI: 10.1021/cn500285h Document Type: Article |
Times cited : (22)
|
References (5)
|